Cetera Advisor Networks’s Quest Diagnostics DGX Stock Holding History

Cetera Advisor Networks’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.53M	Buy	11,469 +273	+2%	+$35.4K	0.01%	1167
2023 Q4	$1.54M	Sell	11,196 -2,267	-17%	-$298K	0.01%	1106
2023 Q3	$1.64M	Sell	13,463 -407	-3%	-$54.2K	0.01%	989
2023 Q2	$1.95M	Sell	13,870 -238	-2%	-$32.8K	0.01%	867
2023 Q1	$2M	Buy	14,108 +193	+1%	+$27.6K	0.01%	838
2022 Q4	$2.18M	Buy	13,915 +7,865	+130%	+$1.13M	0.02%	766
2022 Q3	$742K	Buy	6,050 +167	+3%	+$22K	0.01%	1058
2022 Q2	$782K	Buy	5,883 +1,066	+22%	+$145K	0.01%	1004
2022 Q1	$659K	Buy	4,817 +2,566	+114%	+$358K	0.01%	1129
2021 Q4	$389K	Buy	2,251 +90	+4%	+$13.7K	﹤0.01%	1438
2021 Q3	$314K	Buy	2,161 +119	+6%	+$17.4K	﹤0.01%	1497
2021 Q2	$269K	Buy	+2,042	New	+$267K	﹤0.01%	1578
2020 Q3	–	Sell	-1,038	Closed	-$118K	–	1635
2020 Q2	$118K	Buy	+1,038	New	+$110K	﹤0.01%	1402

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cetera Advisor Networks's DGX Position: Q1 2024 in Review

Cetera Advisor Networks increased its Quest Diagnostics (DGX) stake by 2.4% in Q1 2024, buying an estimated $35.4K and bringing the position to 11,469 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1167.

Cetera Advisor Networks first reported a position in DGX in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.18M in Q4 2022. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Cetera Advisor Networks held 11,469 shares of Quest Diagnostics worth $1.53M as of Q1 2024.
Cetera Advisor Networks bought 273 Quest Diagnostics shares in Q1 2024, an estimated $35.4K.
Quest Diagnostics made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1167 holding.
Cetera Advisor Networks first reported a position in Quest Diagnostics in Q2 2020 and has held it in 13 quarters since.
Cetera Advisor Networks's Quest Diagnostics position peaked at $2.18M in Q4 2022.
819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.